Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retapamulin for MRSA colonization prior to orthopedic surgery
NCT00903279Phase 2Withdrawn
- Sponsor
- Bay Pines VA Healthcare System
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Staphylococcus aureus colonization comparing Placebo with Altabax (2 arms). Primary endpoint: Evaluate efficacy of Retapamulin 1% ointment in eliminating patients MRSA colonization at 30 days. Planned start Aug 2009; status: withdrawn.
02
Drugs
retapamulin
03
Conditions
Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT00903279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00903279.